NUMINUS WELLNESS INC (NUMI.CA) Stock Price, Forecast & Analysis
Canada • Toronto Stock Exchange • TSX:NUMI • CA67054W1032
NUMI.CA Key Statistics, Chart & Performance
The current stock price of NUMI.CA is 0.05 CAD. In the past month the price increased by 25%. In the past year, price decreased by -58.33%.
NUMI.CA Technical Analysis
ChartMill assigns a technical rating of 4 / 10 to NUMI.CA. When comparing the yearly performance of all stocks, NUMI.CA turns out to be only a medium performer in the overall market: it outperformed 45.79% of all stocks.
NUMI.CA Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to NUMI.CA. NUMI.CA has a bad profitability rating. Also its financial health evaluation is rather negative.
NUMI.CA Financial Highlights
Over the last trailing twelve months NUMI.CA reported a non-GAAP Earnings per Share(EPS) of -0.11. The EPS increased by 37.67% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -213.24% | ||
| ROE | -644.74% | ||
| Debt/Equity | 0.95 |
NUMI.CA Forecast & Estimates
For the next year, analysts expect an EPS growth of 58.33% and a revenue growth -18.04% for NUMI.CA
NUMI.CA Ownership
About NUMI.CA
Company Profile
Numinus Wellness, Inc. engages in the development of psychedelic-centered therapeutic products. The company is headquartered in Montreal, Quebec. The firm focuses on advancing traditional and behavioral health treatments with a focus on safe, evidence-based psychedelic-assisted therapies. Its segments include Clinical research operations, Practitioner Training, Clinic network, and Corporate. Clinical research operations segment is focused on licensed psychedelic research and provides clinical research management services to academic institutions and biotechnology companies. Practitioner Training segment is engaged in education and training for research and drug development organizations to support clinical trials and commercialization efforts. Clinic network segment includes wellness clinics, which is engaged in providing clinical services from psychedelic-assisted therapies, transcranial magnetic stimulation, and psychiatric and medical model management. Corporate segment includes finance, marketing, information technology, legal, and human resources.
Company Info
NUMINUS WELLNESS INC
393 Laurier Ave W
MONTREAL QUEBEC V6B 1R4 CA
CEO: Payton Nyquvest
Employees: 0
Phone: 18336864687.0
NUMINUS WELLNESS INC / NUMI.CA FAQ
What does NUMINUS WELLNESS INC do?
Numinus Wellness, Inc. engages in the development of psychedelic-centered therapeutic products. The company is headquartered in Montreal, Quebec. The firm focuses on advancing traditional and behavioral health treatments with a focus on safe, evidence-based psychedelic-assisted therapies. Its segments include Clinical research operations, Practitioner Training, Clinic network, and Corporate. Clinical research operations segment is focused on licensed psychedelic research and provides clinical research management services to academic institutions and biotechnology companies. Practitioner Training segment is engaged in education and training for research and drug development organizations to support clinical trials and commercialization efforts. Clinic network segment includes wellness clinics, which is engaged in providing clinical services from psychedelic-assisted therapies, transcranial magnetic stimulation, and psychiatric and medical model management. Corporate segment includes finance, marketing, information technology, legal, and human resources.
What is the stock price of NUMINUS WELLNESS INC today?
The current stock price of NUMI.CA is 0.05 CAD. The price increased by 42.86% in the last trading session.
What is the dividend status of NUMINUS WELLNESS INC?
NUMI.CA does not pay a dividend.
How is the ChartMill rating for NUMINUS WELLNESS INC?
NUMI.CA has a ChartMill Technical rating of 4 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
What is the GICS sector and industry of NUMI stock?
NUMINUS WELLNESS INC (NUMI.CA) operates in the Health Care sector and the Pharmaceuticals industry.
Can you provide the growth outlook for NUMINUS WELLNESS INC?
The Revenue of NUMINUS WELLNESS INC (NUMI.CA) is expected to decline by -18.04% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.
What is the market capitalization of NUMI stock?
NUMINUS WELLNESS INC (NUMI.CA) has a market capitalization of 16.12M CAD. This makes NUMI.CA a Nano Cap stock.